The identification of drug resistance in ovarian cancer and breast cancer: application of the MTT assay.
Sargent
J
J
Haematology Research Unit, Pembury Hospital, Kent, UK.
Elgie
A
A
Taylor
C G
CG
Wilson
J
J
Alton
P
P
Hill
J G
JG
D000230:Adenocarcinoma / Q000188:drug therapy / Q000401:mortality / Q000473:pathology*; D001943:Breast Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000473:pathology*; D003124:Colorimetry / Q000379:methods*; D004396:Coloring Agents; D004351:Drug Resistance; D004354:Drug Screening Assays, Antitumor / Q000379:methods*; D005240:Feasibility Studies; D005260:Female; D006801:Humans; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000473:pathology*; D010865:Pilot Projects; D011237:Predictive Value of Tests; D011379:Prognosis; D013778:Tetrazolium Salts; D013844:Thiazoles
D004396:Coloring Agents; D013778:Tetrazolium Salts; D013844:Thiazoles; C022616:thiazolyl blue